Showing results (511-520 of 818) with videos related to
Sort By:
Pageof 82
Clinical Neuropharmacology|February 1, 1989
A strategy for measuring the therapeutic properties of new antiparkinsonian drugs, such as +PHNO, in patients with on-off fluctuationsR J Coleman, J A Temlett, N P Quinn, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1977
Plasma DOPA levels and growth hormone response to levodopa in parkinsomismA Galea-Debono, P Jenner, C D Marsden, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 16, 2000
Unilateral lesions of the globus pallidus: report of four patients presenting with focal or segmental dystoniaA Münchau, D Mathen, T Cox, et al.European Journal of Pharmacology|November 19, 1981
Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatmentP Jenner, N M Rupniak, M D Hall, et al.Neuropharmacology|November 1, 1989
Treatment with a selective MAO B inhibitor prevents loss of dopamine in the nucleus accumbens of MPTP-treated common marmosetsS Rose, M Nomoto, E A Jackson, et al.Journal of Neural Transmission. Supplementum|January 1, 1988
Continuous subcutaneous lisuride infusions in Parkinson's diseaseP H Critchley, F Grandas Perez, N P Quinn, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 1997
Paroxysmal exercise-induced dystonia: eight new sporadic cases and a review of the literatureK P Bhatia, V L Soland, M H Bhatt, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1986
Ramsay Hunt syndrome and coeliac disease: a new association?C S Lu, P D Thompson, N P Quinn, et al.Neurosurgery|January 1, 1987
Some experiences of techniques for stimulation of the human cerebral motor cortex through the scalpJ C Rothwell, B L Day, P D Thompson, et al.Clinical Neuropharmacology|October 23, 1997
The long-duration action of levodopa may be due to a postsynaptic effectL Barbato, F Stocchi, A Monge, et al.Pageof 82